|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 29 November 2022, 9:16. The announcement is marked as price sensitive, and is 18 page(s) in length and 2.72MB in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.058% short sold according to ASIC data. It was ranked the 509th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| Chair address and CEO presentation to AGM | 29 November 2022, 9:16 |
| Investor Briefing | 23 November 2022, 8:36 |
| Letter to Shareholders, Notice of AGM & Proxy Form | 27 October 2022, 12:25 |
| AusBioInvest Presentation, including FSGS recruitment update | 27 October 2022, 8:48 |
You must be logged in to post a reply.
Dimerix 